Advertisement

Archive

2012: 107/6 (June) pp. 1009–1194

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245

28 articles
1.

Editorial on Cohen, Dobromirski

J. Ansell (1)

(1) Lenox Hill Hospital, New York, New York, USA

Thromb Haemost 2012 107 6: 1009-1011

https://doi.org/10.1160/TH12-02-0107

[Summary] [Free PDF] [Export citation]
2.

Editorial on Bird et al.

T. Renné (1), A. Gruber (2)

(1) Clinical Chemistry, Department of Molecular Medicine and Surgery and Center of Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; (2) Departments of Biomedical Engineering and Medicine, Oregon Health and Science University, Portland, Oregon, USA

Thromb Haemost 2012 107 6: 1012-1013

https://doi.org/10.1160/TH12-04-0264

[Summary] [Free PDF] [Export citation]
3.

C. Ma (1)

(1) Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

Thromb Haemost 2012 107 6: 1014-1018

https://doi.org/10.1160/TH11-04-0214

[Summary] [Free PDF] [Export citation]
4.

R. Heitmar (1), R. J. Summers (1)

(1) Aston University, School of Life and Health Sciences, Birmingham

Thromb Haemost 2012 107 6: 1019-1026

https://doi.org/10.1160/TH11-11-0810

[Summary] [Free PDF] [Export citation]
5.

W. Ageno (1), A. C. Spyropoulos (2), A. G. G. Turpie (3)

(1) Department of Clinical MedicineUniversity of Insubria,Varese, Italy; (2) University of Rochester Medical Center, Rochester, New York, USA; (3) McMaster University, Hamilton, Ontario, Canada

Thromb Haemost 2012 107 6: 1027-1034

https://doi.org/10.1160/TH11-11-0787

[Summary] [Free PDF] [Export citation]
6.

See also Editorial by Ansell

A. T. Cohen (1), M. Dobromirski (1)

(1) King's College Hospital, London, UK

Thromb Haemost 2012 107 6: 1035-1043

https://doi.org/10.1160/TH11-12-0859

[Summary] [Free PDF] [Export citation]
7.

G. T. Gerotziafas (1, 2), P. Van Dreden (3), M. Chaari (2), V. Galea (1, 2), A. Khaterchi (1, 2), F. Lionnet (4), K. Stankovic-Stojanovic (4), O. Blanc-Brude (5), B. Woodhams (3), M. Maier-Redelsperger (2), R. Girot (2), M. Hatmi (1, 6), I. Elalamy (1, 2)

(1) ER2UPMC, Faculté de Médecine Pierre et Marie Curie, Université Paris VI, France; (2) Service d’Hématologie Biologique Tenon University Hospital, Assistance Publique Hôpitaux de Paris, France; (3) Research and Development, Diagnostica Stago, Gennevilliers, France; (4) Internal Medicine Department, Referral Centre for Adult Sickle Cell Disease, Tenon University Hospital Assistance Public Hospital of Paris, France; (5) ParCC – Paris Center for Cardiovascular Research Inserm UMRs970, Paris, France; (6) Département Infection et Epidémiologie, Institut Pasteur, Paris, France

Thromb Haemost 2012 107 6: 1044-1052

https://doi.org/10.1160/TH11-10-0689

[Summary] [PDF] [Pay per view] [Export citation]
8.
Oral anticoagulation use by patients with atrial fibrillation in Germany
Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients

T. Wilke (1), A. Groth (1), S. Mueller (1), M. Pfannkuche (2), F. Verheyen (3), R. Linder (3), U. Maywald (4), T. Kohlmann (5), Y.-S. Feng (5), G. Breithardt (6), R. Bauersachs (7)

(1) Institut für Pharmakoökonomie und Arzneimittellogistik (IPAM), Hochschule Wismar, Germany; (2) Boehringer Ingelheim Pharma GmbH & Co.KG, Ingelheim, Germany; (3) Wissenschaftliches Institut der TK für Nutzen und Effizienz im Gesundheitswesen (WINEG), Techniker Krankenkasse, Hamburg, Germany; (4) AOK Plus, Dresden, Germany; (5) Institut für Community Medicine, Abteilung Methoden, Universität Greifswald, Germany; (6) Department of Cardiology and Angiology, Universität Münster, Germany; (7) Department of Vascular Medicine, Klinikum Darmstadt GmbH, Darmstadt, Germany

Thromb Haemost 2012 107 6: 1053-1065

https://doi.org/10.1160/TH11-11-0768

[Summary] [PDF] [Pay per view] [Export citation]
9.

D. S. Martin (1, 2), J. S. Pate (1, 3), A. Vercueil (1, 4), P. W. Doyle (1, 5), M. G. Mythen (1), M. P. W. Grocott (1, 6, 7), for the Caudwell Xtreme Everest Research Group

(1) UCL Centre for Altitude, Space and Extreme Environment Medicine, Portex Unit, Institute of Child Health, London, UK; (2) University College London, Division of Surgery and Interventional Science, Royal Free Hospital, London, UK; (3) Centre for Health and Human Performance, London, UK; (4) King's College Hospital, Denmark Hill, London, UK; (5) Anaesthetic Department, Charing Cross Hospital, Fulham Palace Road, London, UK; (6) Integrative Physiology Group, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Sir Henry Wellcome Laboratories, University Hospital Southampton NHS Foundation Trust, Southampton, UK; (7) Critical Care Research Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK

Thromb Haemost 2012 107 6: 1066-1071

https://doi.org/10.1160/TH12-01-0004

[Summary] [PDF] [Pay per view] [Export citation]
10.
Open Access

Online Supplementary Material

G. Auerswald (1), A. Thompson (2), M. Recht (3), D. Brown (4), R. Liesner (5), N. Guzman-Becerra (6), J. Dyck-Jones (6), B. Ewenstein (6), B. Abbuehl (7)

(1) Prof.-Hess-Kinderklinik, Bremen, Germany; (2) Children’s Memorial Hospital, Chicago, Illinois, USA; (3) The Hemophilia Center, Phoenix Children’s Hospital, Phoenix, Arizona, USA; (4) University of Texas Health Science Center-Houston, Houston, Texas, USA; (5) Great Ormond Street Hospital For Children, Haemophilia Centre, London, UK; (6) Baxter Healthcare Corporation, Westlake Village, California, USA; (7) Baxter Innovations GmbH, Vienna, Austria

Thromb Haemost 2012 107 6: 1072-1082

https://doi.org/10.1160/TH11-09-0642

[Summary] [Free PDF] [Export citation]
11.

Online Supplementary Material

M. Wei (1, 2), F. Ye (3), D. Xie (3), Y. Zhu (1), J. Zhu (1), Y. Tao (1), F. Yu (2)

(1) Department of Clinical Pharmacology, Nanjing First Hospital Affiliated to Nanjing Medical University, and Nanjing Cardiovascular Hospital, Nanjing, Jiangsu, China; (2) Department of Clinical Pharmacy, China Pharmaceutical University, Nanjing, China; (3) Department of Cardiology, Nanjing First Hospital Affiliated to Nanjing Medical University, and Nanjing Cardiovascular Hospital, Nanjing, Jiangsu, China

Thromb Haemost 2012 107 6: 1083-1091

https://doi.org/10.1160/TH11-12-0848

[Summary] [PDF] [Pay per view] [Export citation]
12.

K. Leander (1), M. Blombäck (2), H. Wallén (3), S. He (2, 4)

(1) Institute of Environmental Medicine, Division of Cardiovascular Epidemiology, Karolinska Institutet, Stockholm, Sweden; (2) Department of Molecular Medicine & Surgery, Division of Clinical Chemistry/Coagulation Research, Karolinska Institutet, Stockholm, Sweden; (3) Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden; (4) Department of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd Hospital, Stockholm, Sweden

Thromb Haemost 2012 107 6: 1092-1099

https://doi.org/10.1160/TH11-11-0760

[Summary] [PDF] [Pay per view] [Export citation]
13.
Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists
Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics)

See also Editorial by Roldán, Marín

D. Poli (1), E. Antonucci (2), M. Zanazzi (3), E. Grifoni (2), S. Testa (4), W. Ageno (5), G. Palareti (6)

(1) Thrombosis Centre Department of Heart and Vessels, AOU-Careggi, Florence, Italy; (2) Department of Medical and Surgical Critical Care University of Florence, Italy; (3) Renal Unit, AOU-Careggi, Florence, Italy; (4) Haemostasis and Thrombosis Centre A O Istituti Ospitalieri di Cremona, Cremona, Italy; (5) Department of Clinical MedicineUniversity of Insubria,Varese, Italy; (6) Department of Angiology and Blood Coagulation "Marino Golinelli", University Hospital S. Orsola-Malpighi, Bologna, Italy

Thromb Haemost 2012 107 6: 1100-1106

https://doi.org/10.1160/TH11-10-0721

[Summary] [PDF] [Pay per view] [Export citation]
14.

Online Supplementary Material

T. Vanassche (1), A. Kauskot (1), J. Verhaegen (2), W. E. Peetermans (3), J. van Ryn (4), O. Schneewind (5), M. F. Hoylaerts (1), P. Verhamme (1)

(1) Center for Molecular and Vascular Biology, University of Leuven, Belgium; (2) Experimental Laboratory Medicine, University of Leuven, Belgium; (3) Department of Internal Medicine, University of Leuven, Belgium; (4) Department of Cardiometabolic Disease Research, Boehringer Ingelheim Pharmaceuticals, Ridgefield, Conneticut, USA; (5) Department of Microbiology, University of Chicago, Chicago, Illinois, USA

Thromb Haemost 2012 107 6: 1107-1121

https://doi.org/10.1160/TH11-12-0891

[Summary] [PDF] [Pay per view] [Export citation]
15.

M. Skeppholm (1), F. Mobarrez (1), K. Malmqvist (1), H. Wallén (1)

(1) Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden

Thromb Haemost 2012 107 6: 1122-1129

https://doi.org/10.1160/TH11-11-0779

[Summary] [PDF] [Pay per view] [Export citation]
16.

Online Supplementary Material

L. Totani (1), G. Dell’Elba (1), N. Martelli (1), A. Di Santo (1), A. Piccoli (1), C. Amore (1), V. Evangelista (1)

(1) Laboratory of Vascular Biology and Pharmacology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy

Thromb Haemost 2012 107 6: 1130-1140

https://doi.org/10.1160/TH11-12-0867

[Summary] [PDF] [Pay per view] [Export citation]
17.

Online Supplementary Material

See also Editorial by Renné, Gruber

J. E. Bird (1), P. L. Smith (1), X. Wang (2), W. A. Schumacher (1), F. Barbera (1), J.-P. Revelli (3), D. Seiffert (1)

(1) Department of Thrombosis Biology, Bristol-Myers Squibb, Pennington, New Jersey, USA; (2) Agennix, Inc., Princeton, New Jersey, USA; (3) Lexicon Pharmaceuticals, The Woodlands, Texas, USA

Thromb Haemost 2012 107 6: 1141-1150

https://doi.org/10.1160/TH11-10-0682

[Summary] [PDF] [Pay per view] [Export citation]
18.

P. Mismetti (1), C.-M. Samama (2), N. Rosencher (3), C. Vielpeau (4), P. Nguyen (5), B. Deygas (6), E. Presles (6), S. Laporte (7), for The PROPICE Study Group

(1) EA3065 Université Jean Monnet, Saint Etienne, Service de Médecine et Thérapeutique, Unité de Pharmacologie Clinique, CHU Saint-Etienne, France; (2) Hôtel-Dieu de Paris, Université Paris Descartes, Paris, France; (3) Service d'Anesthésie-Réanimation, Hopital Cochin(AP-HP), Université Paris Descartes, Paris, France; (4) Département de Chirurgie Orthopédique, CHRU de Caen, Caen France; (5) Laboratoire d'Hématologie, Université Champagne Ardenne, URCA EA 3801, CHU de Reims, Reims, France; (6) INSERM CIE3, CHU Saint-Etienne, Unité de Pharmacologie Clinique, CHU Saint-Etienne, France; (7) EA3065, Université Jean Monnet, Saint-Etienne, Unité de Pharmacologie Clinique, CHU Saint-Etienne, INSERM CIE3, CHU Saint-Etienne, France

Thromb Haemost 2012 107 6: 1151-1160

https://doi.org/10.1160/TH11-09-0640

[Summary] [PDF] [Pay per view] [Export citation]
19.

Online Supplementary Material

T. Koppara (1), M. Joner (1), G. Bayer (2), K. Steigerwald (1), T. Diener (2), E. Wittchow (2)

(1) Deutsches Herzzentrum München, Munich, Germany; (2) BIOTRONIK SE & Co. KG, Erlangen, Germany

Thromb Haemost 2012 107 6: 1161-1171

https://doi.org/10.1160/TH12-01-0043

[Summary] [PDF] [Pay per view] [Export citation]
20.

J. B. Olesen (1), C. Torp-Pedersen (1), M. L. Hansen (1), G. Y. H. Lip (2)

(1) Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark; (2) University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK

Thromb Haemost 2012 107 6: 1172-1179

https://doi.org/10.1160/TH12-03-0175

[Summary] [PDF] [Pay per view] [Export citation]
  1-20 21-28